AtriCure Inc ATRC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
-
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure Reports Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $53.59
- Day Range
- $52.00–55.25
- 52-Week Range
- $25.36–61.70
- Bid/Ask
- $49.88 / $55.25
- Shares Outstanding
- 50.87M
- Market Cap
- $2.80B
- Volume/Avg
- 2M / 1M
Key Statistics
- Price/Earnings (Normalized)
- 232.53
- Price/Sales
- 4.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.44%
Company Profile
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,350
- Website
- https://www.atricure.com
Valuation
|
Metric
|
ATRC
|
|---|---|
Price/Earnings (Normalized) | 232.53 |
Price/Book Value | 5.28 |
Price/Sales | 4.56 |
Price/Cash Flow | 31.87 |
Price/Earnings
ATRC
Financial Strength
|
Metric
|
ATRC
|
|---|---|
Quick Ratio | 3.02 |
Current Ratio | 4.22 |
Interest Coverage | 2.27 |
Quick Ratio
ATRC
Profitability
|
Metric
|
ATRC
|
|---|---|
Return on Assets (Normalized) | 1.79% |
Return on Equity (Normalized) | 2.37% |
Return on Invested Capital (Normalized) | 2.16% |
Return on Assets
ATRC
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|W#G?tYd | LOCK|L<$ | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|?#$ | LOCK|!B%R | $48B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|%$N^XSN | LOCK|>>#tw | $31B | |||
| ResMed Inc
RMD
| LOCK|?V?%k<Zf | LOCK|G?%Jz | $31B | |||
| Alcon Inc
ALC
| LOCK|@v^h&J# | LOCK|&KwBg | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|shz<&@& | LOCK|q$ | $26B | |||
| Solventum Corp
SOLV
| LOCK|<jwNxzc | LOCK|hv& | $15B | |||
| Baxter International Inc
BAX
| LOCK|vdx | LOCK|pG^< | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|Ry&^S%! | LOCK|&>!#? | $11B | |||
| Repligen Corp
RGEN
| LOCK|T@%DL>c | LOCK|xbW? | $10B |
United States